Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine and cerebral oxygenation during thoracic surgery in elderly patients
ChiCTR2600129164Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in perioperative neurocognitive disorder, postoperative delirium (POD), post-operative cognitive decline (POCD) and 1 more (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Cerebral tissue oxygenation during 20 minutes of single-lung ventilation. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
perioperative neurocognitive disorderpostoperative delirium (POD)post-operative cognitive decline (POCD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2600129164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129164.